Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
about
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosisPD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomyComprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance.Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Different stages in drug development for muscle-invasive bladder cancer.Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease.The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?The landscape of genetics and biomarkers in bladder cancer.Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.Bladder cancer: Multi-omic profiling refines the molecular view.Subtyping Bladder Cancers: Biology vs Bioinformatics.A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort.Current clinical trials in non-muscle invasive bladder cancer.The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer ProgressionCirculating Tumour DNA in Muscle-Invasive Bladder CancerIdentification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer SubtypesA Festschrift in Honor of Edward M. Messing, MD, FACSEMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancerImmunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder CancerNaturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancerRefining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimizationEvaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases
P2860
Q33817493-FA2A4A0A-3C8D-4586-973C-B6D778CB6CE7Q42366515-37042CE6-65D3-4958-BF54-A09D7C36128AQ42378498-4BA2B758-C041-4933-88FC-17EBB3FF1B29Q42516513-896B4384-967B-46E3-8C5D-70E0C366C785Q48022703-4C8A97D8-AA90-45E3-B832-BD7E45E76B1DQ49192905-84D95046-D183-41A7-AD6C-85A8FA4FAD54Q49220712-4FF14EF0-FEED-4249-AFBD-593ABF05D986Q49246529-8304D8AB-94BA-4B53-829A-A850D42E1CDDQ49479865-DEDE7534-D969-4FAD-8008-0EC6C3806DC0Q49526759-4F93E7BA-1C5A-41DF-A626-281DECFE4B8DQ49644212-9B9A4A8E-A0F0-47CE-9044-C63FB2AC8754Q50000734-057B2D2D-A63C-42F6-AE0C-3F12D59EFB86Q52371932-74E4531A-F2AD-4C5F-B80F-72B64B9A2C12Q53124991-D427E50E-2CD9-47B7-B349-1674B70728D1Q54964281-5B43E034-BBD4-4BA0-A35A-C9DACF1501C1Q55314159-9A34CDF1-C5E6-4965-9866-99FB04B9D8A6Q55397522-6391AE7A-BB44-46E8-B600-D14286FCEF76Q56334243-0CD07EE3-57FB-4F33-87EB-A0EF663E2246Q57166936-C2AFA482-FFE1-450A-B5E5-EAED2EC38D72Q57490070-CA8B6099-D8AB-48A9-A3CB-BC54A19FEF03Q58691149-1613A354-C554-4C1F-B79A-C30B2F3684B3Q58695604-7CB39E5A-669C-42BE-984C-316FCF99008BQ58705140-7D490A1B-4081-4831-B7A9-46983A72D988Q58795373-907C068F-87FC-488A-BBEC-BA5E738130C5Q58804615-44CF555D-49ED-4F30-A8FC-4598200AE1FCQ58804619-1F2750DB-407B-4D5E-B999-440610C01F7E
P2860
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@en
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@nl
type
label
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@en
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@nl
prefLabel
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@en
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@nl
P2093
P1433
P1476
Impact of Molecular Subtypes i ...... fter Neoadjuvant Chemotherapy.
@en
P2093
Bas W G van Rhijn
Beatrix Palmer-Aronsten
Bernhard Kiss
Brian Winters
Christine Buerki
David J McConkey
Elisabeth E Fransen van de Putte
Ellen C Zwarthoff
Ewan A Gibb
George N Thalmann
P304
P356
10.1016/J.EURURO.2017.03.030
P407
P577
2017-04-05T00:00:00Z